Low rate of seroconversion analyzing QuantiFERON TB-gold testing in patients with psoriasis and hidradenitis suppurativa taking biologic therapy at an academic center in New York City. Academic Article uri icon

Overview

publication date

  • May 10, 2024

Identity

PubMed Central ID

  • PMC11254735

Scopus Document Identifier

  • 85196670754

Digital Object Identifier (DOI)

  • 10.1016/j.jdin.2024.04.004

PubMed ID

  • 39026561

Additional Document Info

volume

  • 16